+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Toxoplasma Gondii Recombinant Antigen Market - Global Forecast 2025-2030- Product Image
Toxoplasma Gondii Recombinant Antigen Market - Global Forecast 2025-2030- Product Image
Sale

Toxoplasma Gondii Recombinant Antigen Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6080705
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Toxoplasma Gondii recombinant antigen market is transforming diagnostic and research solutions through precision-engineered, scalable reagents that address critical needs in clinical, veterinary, and research applications. Senior decision-makers seeking reliable and innovative antigen sources will find that shifting technological, regulatory, and supply chain landscapes are redefining both capabilities and competitive positioning in this space.

Market Snapshot: Toxoplasma Gondii Recombinant Antigen

Current advancements in the Toxoplasma Gondii recombinant antigen market are streamlining diagnostics and raising standards for global health monitoring. The sector’s growth is propelled by the increasing adoption of high-specificity recombinant antigens in serological assays, multi-site research collaborations, and heightened demand for accurate maternal and immunocompromised patient testing. Enhanced recombinant expression capabilities ensure standardized product quality, attracting organizations focused on integrated, reproducible results.

Scope & Segmentation

This report provides a comprehensive analysis of the Toxoplasma Gondii recombinant antigen landscape, differentiating the market by product type, application, end user, technology, and regional presence. Each segmentation reveals evolving user needs, supply chain priorities, and regulatory drivers.

  • Product Types: ELISA kits for IgG avidity testing, IgG detection, IgM detection; rapid test kits, such as dipstick test formats and lateral flow immunoassays; Western blot kits for qualitative and quantitative purposes.
  • Applications: Clinical diagnosis, research use, and veterinary diagnostic practices.
  • End Users: Academic institutes, diagnostic laboratories, hospitals, pharmaceutical companies, and research institutes.
  • Technologies: Enzyme-linked immunosorbent assay platforms, immunochromatographic assays, polymerase chain reaction, and Western blot assay methodologies.
  • Regions: Americas (including the U.S., Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (with prominent markets across the U.K., Germany, France, and more); Asia-Pacific (notably China, India, Japan, Australia, and additional key economies).

Key Takeaways for Decision-Makers

  • Recombinant antigens derived from Toxoplasma Gondii strains now outperform legacy lysates in assay reproducibility, batch quality, and diagnostic confidence.
  • Flexibility in antigen engineering enables design of chimeric constructs focusing on immunodominant epitopes, minimizing cross-reactivity and enhancing result accuracy across immunoassays.
  • Growing demand for reliable serological screening, especially in prenatal and immunocompromised patient care, intensifies the need for advanced antigen platforms and streamlined manufacturing.
  • Technological integration, including automated assay formats and on-demand cartridge systems, accelerates diagnostic throughput and reduces operator variability in both centralized and decentralized settings.
  • Collaborative industry–academia partnerships and region-specific alliances are rapidly advancing the pace of antigen discovery, validation, and global distribution.
  • Distinct focus areas, such as veterinary diagnostics and point-of-care formats, allow agile biotech ventures and established firms alike to target niche segments and respond to emerging health challenges.

Tariff Impact: United States 2025 Adjustments

Upcoming U.S. tariff changes in 2025 are prompting recombinant antigen producers to reassess global sourcing and procurement. Manufacturers are adopting dual sourcing and nearshoring operations to mitigate cost pressures, ensure regulatory alignment, and preserve agility amid shifting import duties. Distribution agreements are also being updated to protect margins from future tariff escalations. These measures highlight the sector’s need for proactive supply chain management and real-time trade policy monitoring.

Methodology & Data Sources

The findings in this report are based on a blend of primary interviews with subject matter experts, direct observations in manufacturing and diagnostic settings, and a thorough review of scientific literature, peer-reviewed studies, and regulatory documentation. Data triangulation and field validation ensure the accuracy and integrity of each insight.

Why This Report Matters

  • Equip leadership with a forward-looking analysis of market shifts, supporting informed investment and sourcing decisions in recombinant antigen strategies.
  • Deliver actionable insights into technology trends, regulatory developments, and segment opportunities, enhancing competitive advantage and operational resilience.

Conclusion

The Toxoplasma Gondii recombinant antigen market is shaped by technology innovation, regional dynamics, regulatory progress, and cross-sector partnerships. Organizations that leverage these strategic insights can unlock value, accelerate adoption, and foster diagnostic excellence in a rapidly evolving environment.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of multiplex serological assays using recombinant Toxoplasma gondii antigens for comprehensive diagnostic profiling
5.2. Increasing investment in high-throughput expression systems to enhance yield and purity of recombinant Toxoplasma gondii antigens
5.3. Emergence of rapid point-of-care testing platforms integrating Toxoplasma gondii recombinant antigens for field diagnostics
5.4. Strategic collaborations between biotech firms and diagnostic labs to accelerate validation of novel Toxoplasma gondii antigen panels
5.5. Regulatory alignment initiatives facilitating global approval of recombinant Toxoplasma gondii antigens in prenatal screening
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Toxoplasma Gondii Recombinant Antigen Market, by Product Type
8.1. Introduction
8.2. Elisa Kit
8.2.1. Igg Avidity Testing
8.2.2. Igg Detection
8.2.3. Igm Detection
8.3. Rapid Test Kit
8.3.1. Dipstick Test
8.3.2. Lateral Flow Immunoassay
8.4. Western Blot Kit
8.4.1. Qualitative Western Blot
8.4.2. Quantitative Western Blot
9. Toxoplasma Gondii Recombinant Antigen Market, by Application
9.1. Introduction
9.2. Clinical Diagnosis
9.3. Research Use
9.4. Veterinary Diagnosis
10. Toxoplasma Gondii Recombinant Antigen Market, by End User
10.1. Introduction
10.2. Academic Institutes
10.3. Diagnostic Laboratories
10.4. Hospitals
10.5. Pharmaceutical Companies
10.6. Research Institutes
11. Toxoplasma Gondii Recombinant Antigen Market, by Technology
11.1. Introduction
11.2. Enzyme Linked Immunosorbent Assay
11.3. Immunochromatographic Assay
11.4. Polymerase Chain Reaction
11.5. Western Blot Assay
12. Americas Toxoplasma Gondii Recombinant Antigen Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Toxoplasma Gondii Recombinant Antigen Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Toxoplasma Gondii Recombinant Antigen Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific, Inc.
15.3.2. F. Hoffmann-La Roche Ltd
15.3.3. Merck KGaA
15.3.4. Bio-Rad Laboratories, Inc.
15.3.5. QIAGEN N.V.
15.3.6. Bio-Techne Corporation
15.3.7. Abbott Laboratories
15.3.8. Abcam plc
15.3.9. GenScript Biotech Corporation
15.3.10. Meridian Bioscience, Inc.
16. Research AI17. Research Statistics18. Research Contacts19. Research Articles20. Appendix
List of Figures
FIGURE 1. TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET: RESEARCHAI
FIGURE 24. TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET: RESEARCHSTATISTICS
FIGURE 25. TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET: RESEARCHCONTACTS
FIGURE 26. TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY IGG AVIDITY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY IGG AVIDITY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY IGG DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY IGG DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY IGM DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY IGM DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY DIPSTICK TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY DIPSTICK TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY QUALITATIVE WESTERN BLOT, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY QUALITATIVE WESTERN BLOT, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY QUANTITATIVE WESTERN BLOT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY QUANTITATIVE WESTERN BLOT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RESEARCH USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RESEARCH USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY VETERINARY DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY VETERINARY DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 99. CANADA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. CANADA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. CANADA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2018-2024 (USD MILLION)
TABLE 102. CANADA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2025-2030 (USD MILLION)
TABLE 103. CANADA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2018-2024 (USD MILLION)
TABLE 104. CANADA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2025-2030 (USD MILLION)
TABLE 105. CANADA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2018-2024 (USD MILLION)
TABLE 106. CANADA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2025-2030 (USD MILLION)
TABLE 107. CANADA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. CANADA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. CANADA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. CANADA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. CANADA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 112. CANADA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 113. MEXICO TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. MEXICO TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. MEXICO TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2018-2024 (USD MILLION)
TABLE 116. MEXICO TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2025-2030 (USD MILLION)
TABLE 117. MEXICO TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2018-2024 (USD MILLION)
TABLE 118. MEXICO TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2025-2030 (USD MILLION)
TABLE 119. MEXICO TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2018-2024 (USD MILLION)
TABLE 120. MEXICO TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2025-2030 (USD MILLION)
TABLE 121. MEXICO TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. MEXICO TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. MEXICO TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. MEXICO TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. MEXICO TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 126. MEXICO TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 185. GERMANY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. GERMANY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. GERMANY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2018-2024 (USD MILLION)
TABLE 188. GERMANY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2025-2030 (USD MILLION)
TABLE 189. GERMANY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2018-2024 (USD MILLION)
TABLE 190. GERMANY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2025-2030 (USD MILLION)
TABLE 191. GERMANY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2018-2024 (USD MILLION)
TABLE 192. GERMANY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2025-2030 (USD MILLION)
TABLE 193. GERMANY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. GERMANY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. GERMANY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. GERMANY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. GERMANY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 198. GERMANY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 199. FRANCE TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. FRANCE TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. FRANCE TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2018-2024 (USD MILLION)
TABLE 202. FRANCE TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2025-2030 (USD MILLION)
TABLE 203. FRANCE TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2018-2024 (USD MILLION)
TABLE 204. FRANCE TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2025-2030 (USD MILLION)
TABLE 205. FRANCE TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2018-2024 (USD MILLION)
TABLE 206. FRANCE TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2025-2030 (USD MILLION)
TABLE 207. FRANCE TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. FRANCE TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. FRANCE TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. FRANCE TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. FRANCE TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 212. FRANCE TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. ITALY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 228. ITALY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 229. ITALY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2018-2024 (USD MILLION)
TABLE 230. ITALY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2025-2030 (USD MILLION)
TABLE 231. ITALY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2018-2024 (USD MILLION)
TABLE 232. ITALY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2025-2030 (USD MILLION)
TABLE 233. ITALY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2018-2024 (USD MILLION)
TABLE 234. ITALY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2025-2030 (USD MILLION)
TABLE 235. ITALY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. ITALY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. ITALY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. ITALY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. ITALY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 240. ITALY TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 241. SPAIN TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. SPAIN TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. SPAIN TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2018-2024 (USD MILLION)
TABLE 244. SPAIN TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2025-2030 (USD MILLION)
TABLE 245. SPAIN TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2018-2024 (USD MILLION)
TABLE 246. SPAIN TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2025-2030 (USD MILLION)
TABLE 247. SPAIN TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2018-2024 (USD MILLION)
TABLE 248. SPAIN TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2025-2030 (USD MILLION)
TABLE 249. SPAIN TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. SPAIN TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. SPAIN TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. SPAIN TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. SPAIN TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 254. SPAIN TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY RAPID TEST KIT, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY WESTERN BLOT KIT, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. SAUDI ARABIA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA TOXOPLASMA GONDII RECOMBINANT ANTIGEN MARKET SIZE, BY ELISA KIT, 2025-2030 (USD

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Toxoplasma Gondii Recombinant Antigen market report include:
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • QIAGEN N.V.
  • Bio-Techne Corporation
  • Abbott Laboratories
  • Abcam plc
  • GenScript Biotech Corporation
  • Meridian Bioscience, Inc.

Related Topics

Related Reports

Diagnostic Substances Market - Global Forecast 2025-2032 - Product Image

Diagnostic Substances Market - Global Forecast 2025-2032

  • Report
  • 181 Pages
  • Global
From
Diagnostic Specialty Antibodies Market Report 2025 - Product Image

Diagnostic Specialty Antibodies Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Diagnostic Specialty Antibodies - Global Strategic Business Report - Product Image

Diagnostic Specialty Antibodies - Global Strategic Business Report

  • Report
  • 367 Pages
  • Global
From
Diagnostic Specialty Antibodies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Diagnostic Specialty Antibodies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Viral Diagnostic Test Kits Market Report 2025 - Product Image

Viral Diagnostic Test Kits Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.